Microscopic evidence demonstrated a strictly biotrophic lifestyle of the scab fungus on growing apple leaves and characterised its hemibiotrophy as the combination of biotrophy and saprotrophy not described before. The pathogen-host interface was characterised by the formation of knob-like structures of the fungal stroma appressed to epidermal cells as early as 1 day after host penetration, very thin fan-shaped cells covering large parts of the host cell lumen, and enzymatic cuticle penetration from the subcuticular space limited to the protruding conidiophores. The cell wall had numerous orifices, facilitating intimate contact with the host tissue.
View Article and Find Full Text PDFCell growth and gene expression are heterogeneous processes at the single-cell level, leading to the emergence of multiple physiological states within bacterial populations. Aging is a known deterministic driver of growth asymmetry; however, its role in gene expression heterogeneity remains elusive. Here, we show that aging mother cells undergo a progressive decline in old pole activity, generating asymmetry in protein partitioning, gene expression, and cell morphology.
View Article and Find Full Text PDFImmunoglobulins for intravenous use (IVIgs) and subcutaneous use (SCIgs) can prevent recurrent and severe infections in patients with secondary antibody deficiencies that are frequently linked to haematological/oncological malignancies as well as other clinical conditions and their respective treatments. Even so, as IVIgs and SCIgs are costly and their supply is limited, their clinical use must be optimised. The aim of this position paper is to provide structured practical guidance on the optimal use of IVIgs and SCIgs in secondary antibody deficiencies, particularly in haematological and oncological practice.
View Article and Find Full Text PDFBackground: The alignment between objective scores and patient-reported outcome measures (PROMs) is underexplored. This study aimed to assess changes in Nasal Polyp Score (NPS) and Sino-Nasal Outcome Test (SNOT) scores in chronic rhinosinusitis with nasal polyps (CRSwNP) patients undergoing dupilumab treatment and explore correlations between these scores.
Methods: CRSwNP patients received dupilumab therapy for six months.